Deepfakes (also known as digital replicas) are created when sophisticated AI technology generates or alters audio-visual content to misrepresent someone or something. Often a person's voice or appearance is digitally...more
8/15/2025
/ Advertising ,
Artificial Intelligence ,
Biometric Information ,
China ,
Copyright ,
Data Protection ,
Deep Fake ,
EU ,
Germany ,
Name and Likeness ,
New Legislation ,
Regulatory Agenda ,
Regulatory Requirements ,
Technology ,
Trademarks ,
UK ,
Unfair Competition
AI developers and content owners in the UK and around the world are eagerly anticipating the outcome of the Getty Images v. Stability AI trial. One of the most commercially significant aspects of the case is the relevance of...more
The “unwilling licensee” issue has been a vexed one, with uncertainty as to whether such a concept exists, its relevance, and what an implementer must do to avoid becoming one. As for the concept of FRAND itself, there is no...more
The UK Supreme Court has unanimously ruled that trade mark owners should pay the costs of implementing a court order requiring UK ISPs to block access to websites selling counterfeit goods. This is a reversal of previous...more
The vexed question of how to enforce second medical use patents has dominated the headlines in the last half year. The case of Warner-Lambert v Actavis1 in the English High Court highlighted the serious difficulties...more
9/23/2015
/ Actavis Inc. ,
AstraZeneca ,
Claim Construction ,
EU ,
European Court of Justice (ECJ) ,
FRAND ,
Gilead Sciences ,
Hospira ,
Injunctions ,
IP License ,
IP Portfolio ,
Jurisdiction ,
Life Sciences ,
Patent Infringement ,
Patent Litigation ,
Patent Portfolios ,
Patents ,
Pharmaceutical Patents ,
Teva Pharmaceuticals ,
UK ,
UK Patents Act